İpravent 0.5 mg/2.5 mL + 2.5 mg/2.5 mL Nebulization Solution is a highly effective, ready-to-use inhalation therapy formulated for the management and relief of severe bronchospasm associated with Chronic Obstructive Pulmonary Disease (COPD) and acute asthma exacerbations.
Combining an anticholinergic agent with a beta2-adrenergic agonist, this dual-action combination solution provides synergistic bronchodilation, delivering rapid and prolonged relief to improve patient airflow and lung function. Formulated as a sterile, preservative-free solution for single-dose nebulization, it ensures maximum safety, stability, and ease of administration in both clinical and home care settings. Manufactured in our advanced production facilities complying with strict international GMP standards, İpravent represents our commitment to high-quality, accessible respiratory care.
